Thrombin inhibitors and cardiopulmonary bypass.
作者信息
Merry Alan
机构信息
Auckland City Hospital, Auckland, New Zealand.
出版信息
J Extra Corpor Technol. 2006 Mar;38(1):52-6.
Abstract
摘要
相似文献
1
Thrombin inhibitors and cardiopulmonary bypass.凝血酶抑制剂与体外循环
J Extra Corpor Technol. 2006 Mar;38(1):52-6.
2
Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.在体外，阿加曲班、比伐卢定和重组水蛭素在降低血栓扩展和强度方面，不如肝素激活的抗凝血酶有效。
J Heart Lung Transplant. 2006 Jun;25(6):653-63. doi: 10.1016/j.healun.2006.02.010. Epub 2006 May 2.
3
Thrombin inhibitors and anti-coagulants on thrombin-induced embolisation in rabbit cranial vasculature.凝血酶抑制剂和抗凝剂对兔颅脑血管中凝血酶诱导栓塞的作用。
Eur J Pharmacol. 1994 Oct 24;264(2):183-90. doi: 10.1016/0014-2999(94)00464-1.
4
Use of bivalirudin as an anticoagulant during cardiopulmonary bypass.在体外循环期间使用比伐卢定作为抗凝剂。
J Extra Corpor Technol. 2005 Sep;37(3):296-302.
5
Bivalirudin for anticoagulation during hypothermic cardiopulmonary bypass and recombinant factor VIIa for iatrogenic coagulopathy.比伐卢定用于低温体外循环期间的抗凝，重组因子 VIIa 用于医源性凝血障碍。
Ann Pharmacother. 2011 Sep;45(9):e47. doi: 10.1345/aph.1P785. Epub 2011 Aug 23.
6
Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass.体外循环期间使用比伐卢定抗凝获得良好结果。
Ann Thorac Surg. 2003 Jan;75(1):264-5. doi: 10.1016/s0003-4975(02)04299-6.
7
[Direct thrombin antagonists].[直接凝血酶拮抗剂]
Herz. 2001 Apr;26 Suppl 1:46-52. doi: 10.1007/pl00014032.
8
An assay to monitor bivalirudin levels on cardiopulmonary bypass.一种用于监测体外循环中比伐卢定水平的检测方法。
Ann Thorac Surg. 2011 Jul;92(1):332-4. doi: 10.1016/j.athoracsur.2010.12.064.
9
Direct thrombin inhibitors in patients with mechanical heart valves: ready for clinical trials?
Thromb Haemost. 2009 Jun;101(6):995-6.
10
Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery.比伐芦定与肝素及鱼精蛋白用于非体外循环冠状动脉搭桥手术的比较
Ann Thorac Surg. 2004 Mar;77(3):925-31; discussion 931. doi: 10.1016/j.athoracsur.2003.09.061.
引用本文的文献
1
Innovative strategies in coagulation management for cardiothoracic surgery: a narrative review of pharmacological and nonpharmacological approaches.心胸外科手术凝血管理的创新策略：药理学和非药理学方法的叙述性综述
J Cardiothorac Surg. 2025 Jul 16;20(1):305. doi: 10.1186/s13019-025-03406-w.
本文引用的文献
1
Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery.比伐芦定与肝素及鱼精蛋白用于非体外循环冠状动脉搭桥手术的比较
Ann Thorac Surg. 2004 Mar;77(3):925-31; discussion 931. doi: 10.1016/j.athoracsur.2003.09.061.
2
Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia.肝素诱导的血小板减少症患者中与重组水蛭素相关的过敏反应和类过敏反应。
Circulation. 2003 Oct 28;108(17):2062-5. doi: 10.1161/01.CIR.0000096056.37269.14. Epub 2003 Oct 20.
3
Development and validation of a prediction model for strokes after coronary artery bypass grafting.冠状动脉旁路移植术后中风预测模型的开发与验证
Ann Thorac Surg. 2003 Aug;76(2):436-43. doi: 10.1016/s0003-4975(03)00528-9.
4
Successful use of Argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient.
Ann Thorac Surg. 2003 May;75(5):1622-4. doi: 10.1016/s0003-4975(02)04782-3.
5
Mortality after total hip and knee arthroplasty in a medium-volume university practice.中等规模大学附属医院全髋关节和全膝关节置换术后的死亡率
J Arthroplasty. 2003 Apr;18(3):278-85. doi: 10.1054/arth.2003.50095.
6
Correlation of point-of-care ecarin clotting time versus activated clotting time with bivalirudin concentrations.即时检测的依卡凝血时间与活化凝血时间和比伐卢定浓度的相关性。
Am J Cardiol. 2003 May 1;91(9):1110-3. doi: 10.1016/s0002-9149(03)00159-0.
7
Anti-platelet factor 4/heparin antibodies: an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes.抗血小板因子4/肝素抗体：急性冠状动脉缺血综合征后30天心肌梗死的独立预测指标。
Circulation. 2003 May 13;107(18):2307-12. doi: 10.1161/01.CIR.0000066696.57519.AF. Epub 2003 Apr 21.
8
Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use.肝素诱导的血小板减少症与体外循环：围手术期使用阿加曲班
Ann Thorac Surg. 2003 Feb;75(2):577-9. doi: 10.1016/s0003-4975(02)04309-6.
9
Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.比伐卢定与临时糖蛋白IIb/IIIa受体阻滞剂联用与肝素及计划使用糖蛋白IIb/IIIa受体阻滞剂在经皮冠状动脉介入治疗中的比较：REPLACE-2随机试验
JAMA. 2003 Feb 19;289(7):853-63. doi: 10.1001/jama.289.7.853.
10
Bivalirudin monitored with the ecarin clotting time for anticoagulation during cardiopulmonary bypass.
Anesth Analg. 2003 Feb;96(2):383-6, table of contents. doi: 10.1097/00000539-200302000-00015.
Zotero 插件